Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis.

Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis. Lupus. 2020 Apr 16;:961203320918011 Authors: Ganguly S, Kumar U, Gupta N, Guleria A, Majumdar S, Phatak S, Chaurasia S, Kumar S, Aggarwal A, Kumar D, Misra R PMID: 32299281 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32299281?dopt=Abstract

Source: Lupus - April 15, 2020 Category: Rheumatology Authors: Ganguly S, Kumar U, Gupta N, Guleria A, Majumdar S, Phatak S, Chaurasia S, Kumar S, Aggarwal A, Kumar D, Misra R Tags: Lupus Source Type: research

More News: Lupus | Nephritis | Rheumatology